Peers of KALA BIO Inc (KALA)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
-7.13x
As of Sep 29, 2023
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Sep 29, 2023 | -7.13x |
| Sep 28, 2023 | -7.55x |
| Sep 27, 2023 | -6.77x |
| Sep 26, 2023 | -3.44x |
| Sep 25, 2023 | -1.32x |
| Sep 22, 2023 | 1.61x |
| Sep 21, 2023 | 3.70x |
| Sep 20, 2023 | 3.52x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison